Conversations on Twitter :
- "Is there an app for that?" Thought-provoking post & discussion on how oncologists sort through new anticancer drugs.
- Aging fathers & rising mutations: Nature paper sparks discussion ranging from Hugh Hefner's offspring to schizophrenia prevalence.
@FierceBiotech: From FierceCRO: Researchers bristle at India's proposed trial reforms. Story | Follow @FierceBiotech
@JohnCFierce: Fate Therapeutics raised a bit more than $9M for their stem cell work. Run by biotech vet Bill Rastetter. More | Follow @JohnCFierce
@RyanMFierce: J&J is heading into Phase III with a new RA drug, add on big inflammation biz, not sure what hopes are for this one. More | Follow @RyanMFierce
> Are trials for psychiatric drugs enrolling the wrong patients? Report
> The CEO of the biotech company Tigenix sounded upbeat about the prospects of nailing down a partner for CX601 by the end of the year. Story
> The Oregon Translational Research and Development in Portland faces a major decision next month when state offices make a call on providing $2 million to help keep the organization vital in driving biotech growth in the region. More
> The FDA awarded the biotech Xoma orphan drug status for its lead drug candidate gevokizumab for treating an eye ailment called uveitis. Article
> Samsung, known widely for its consumer electronics, has jumped into the genome analysis game. Item
> EU inspectors green-lighted Alexza's plan after the FDA raised concerns about the facility. Article
Pharma News
@FiercePharma: Thumbs up from HSBC on India's pharma sector. Dr Reddy's, Sun Pharma, Cipla are its faves--Reuters. More | Follow @FiercePharma
> FDA bears greater ethical burden in post-marketing trials, NEJM says. Article
> Indian sales reps strike to demand strict drug-promo rules. More
> AZ's Nexium tops Q2 sales ranks, with BMS' Abilify on its heels. Report
> Pfizer, Mylan plan joint attack on Japanese generics market. Story
@FierceMedDev: The FBI arrested two former ArthoCare execs, charging them with defrauding investors of $400M. Release | Follow @FierceMedDev
@MarkHFierce: Faridabad in India is becoming a huge hub for medical device and equipment manufacturers. More | Follow @MarkHFierce
@DamianFierce: CareFusion's fourth Class I recall of the summer deals with is Alaris infusion pumps. Article | Follow @DamianFierce
> Varian Medical chooses South Korea for overseas subsidiary. News
> Devicemakers cautiously optimistic after meeting with FDA chief. Story
> GI Dynamics gains FDA nod for obesity device pivotal trial. Item
> CareFusion hit with another Class I recall over pump. News
Vaccines News
> Bavarian Nordic in peril if U.S. nixes smallpox vaccine order. Report
> Labs, NIH zero in on painless vaccine technology. More
> NIAID provides $7.8M in grants for HIV research. Article
> PATH Malaria Vaccine Initiative creates reference lab. Item
> Merck's Varivax slashes U.S. chickenpox cases. Story
Pharma Manufacturing News
> India's Faridabad builds manufacturing mass. Story
> EU inspectors give Alexza plant the approval that FDA denied it. News
> West tapping growth in India, Asia. More
> Forfeiture of 27 ANDAs is a small piece of Ranbaxy penalties. Item
And Finally… Researchers used DNA sequencing in a battle to thwart a killer strain of the bug Klebsiella pneumonia in an NIH hospital. Article (sub. req.)